SCHEMBL31514623

SCHEMBL31514623

Fc1cccc(F)c1Nc1ncnc2cc(-c3ccc(N4CCOCC4)nc3)ccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 6/20 0.52
▸ ERBB2 P04626 1/20 0.45
▸ TDO2 P48775 1/20 0.45
▸ CCNT1 O60563 1/20 0.44
▸ CCNE1 P24864 1/20 0.44
▸ CDK2 P24941 1/20 0.44
▸ CDK9 P50750 1/20 0.44
▸ MAP4K4 O95819 1/20 0.44
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ RAF1 P04049 1/20 0.43
▸ BRAF P15056 1/20 0.43
▸ ERN1 O75460 1/20 0.43
▸ IRAK4 Q9NWZ3 2/20 0.42
▸ EGFR P00533 1/20 0.41
▸ SYK P43405 1/20 0.41
▸ GAK O14976 1/20 0.41
▸ AURKA O14965 1/20 0.41
▸ KIT P10721 1/20 0.41
▸ FLT3 P36888 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31514565 0.90 CNR2 (0.54) CNR2TDO2MAP4K4EGFRAURKB
SCHEMBL31514609 0.89 HTR2A (0.50) CNR2TDO2MAP4K4RAF1BRAF
SCHEMBL31514563 0.88 EGFR (0.51) TDO2MAP4K4RAF1BRAFEGFR
SCHEMBL31514581 0.87 EGFR (0.54) CNR2MAP4K4EGFRAURKAKIT
SCHEMBL31514625 0.85 TDO2 (0.48) CNR2TDO2MAP4K4RAF1BRAF
SCHEMBL31514592 0.85 TDO2 (0.48) CNR2TDO2MAP4K4ERN1EGFR
SCHEMBL31514567 0.85 EGFR (0.49) CNR2ERBB2TDO2MAP4K4EGFR
SCHEMBL31514559 0.85 MAP4K4 (0.51) CNR2TDO2MAP4K4EGFRKIT
SCHEMBL31514586 0.84 EGFR (0.48) TDO2MAP4K4RAF1BRAFEGFR
SCHEMBL31514587 0.83 EGFR (0.54) CNR2CDK2MAP4K4EGFRAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119912429-A Quinazoline compound with anti-inflammatory activity or pharmaceutically acceptable salt thereof, pharmaceutical composition and application thereof 安徽医科大学 2025-05-02 — — CN disclosed
Send feedback